Via Rao Selected Research

Fluvoxamine (Luvox)

6/2023	Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial.
1/2023	Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial.
1/2022	Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Via Rao Research Topics

Disease

4	COVID-19 05/2024 - 01/2022
2	Post-Acute COVID-19 Syndrome 05/2024 - 06/2023
1	Nausea 01/2023
1	Chills 01/2023
1	Myalgia 01/2023
1	Cough 01/2023
1	Diarrhea 01/2023
1	Fatigue 01/2023
1	Fever (Fevers) 01/2023
1	Headache (Headaches) 01/2023
1	Infections 01/2022

Drug/Important Bio-Agent (IBA)

4	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 01/2022
3	Ivermectin (Mectizan)FDA Link 06/2023 - 01/2022
3	Fluvoxamine (Luvox)FDA LinkGeneric 06/2023 - 01/2022
2	Antiviral Agents (Antivirals)IBA 05/2024 - 06/2023
1	VaccinesIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023

Therapy/Procedure

2	Therapeutics 06/2023 - 01/2023